Compound heterozygosity of HLA‐DRB3*01:01 and HLA‐DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia
- 7 June 2012
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 53 (2) , 344-352
Abstract
BACKGROUND: Fetal neonatal alloimmune thrombocytopenia (FNAIT) is a life‐threatening bleeding disorder in the fetus or neonate caused by maternal alloantibodies directed against fetal platelet (PLT) antigens inherited from the father. The immune‐dominant antigen leading to severe FNAIT is the human PLT antigen (HPA)‐1, whose polymorphism constitutes an epitope for human leukocyte antigens (HLAs), usually DRB3*0101 leading to an immune response. STUDY DESIGN AND METHODS: In this study our aims were to find whether other allele variants of the β subunit of the HLA‐DR family specifically focused on the HLA residues that bind Position 33 of the HPA‐1 integrin contribute to FNAIT development and affect response to treatment and whether coexistence of both anti‐HPA‐1a and anti‐HLA Class I specific against the father's antigens leads to a more severe thrombocytopenia in the newborn. We examine the genotype of 23 mothers to newborns with FNAIT compared to a control group. RESULTS: Our results suggested that, when HPA‐1 incompatibility with the husband is found, the presence of two HLA alleles (DRB3*01:01 and DRB4*01:01) in the mother increases the risk and severity of FNAIT and reduces the success of a preventive immunoglobulin G treatment. We provide a structural model for the molecular basis of the rational effects of the different HLA alleles. In addition, we found that the presence of both anti‐HPA‐1 and anti‐HLAs did not aggravate FNAIT in comparison to mothers harboring only anti‐HPA‐1. CONCLUSION: Overall, we suggest that a specific genotyping of the mother in relation to HLA‐DRB as well as HPA‐1 can serve as an antenatal diagnostic tool, particularly in siblings of women who gave birth to neonates with FNAIT.Keywords
This publication has 28 references indexed in Scilit:
- Molecular insight into human platelet antigens: structural and evolutionary conservation analyses offer new perspective to immunogenic disordersTransfusion, 2010
- Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetusAmerican Journal of Obstetrics and Gynecology, 2010
- Evidence for the Specificity for Platelet HPA-1a Alloepitope and the Presenting HLA-DR52a of Diverse Antigen-Specific Helper T Cell Clones from Alloimmunized MothersThe Journal of Immunology, 2009
- T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a–specific, HLA-DRB3*0101–restricted CD4+ T cellsBlood, 2009
- Diagnosis and Management of Neonatal Alloimmune ThrombocytopeniaTransfusion Medicine Reviews, 2008
- Crystallographic Structure of the Human Leukocyte Antigen DRA, DRB3*0101: Models of a Directional Alloimmune Response and AutoimmunityJournal of Molecular Biology, 2007
- Fetal Alloimmune ThrombocytopeniaNew England Journal of Medicine, 1997
- HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loadingCell, 1995
- The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.Journal of Clinical Investigation, 1989
- MATERNAL ANTI-HLA ANTIBODIES AND NEONATAL THROMBOCYTOPENIAThe Lancet, 1981